Quantcast

Latest rheumatism Stories

2011-05-25 00:30:00

EAST HANOVER, N.J., May 25, 2011 /PRNewswire/ -- Novartis announced today results of two pivotal Phase III trials in patients with severe gouty arthritis, showing that ACZ885 (canakinumab) provided superior pain relief and reduced the risk of suffering new attacks by up to 68% compared to an injectable steroid (triamcinolone acetonide, TA) used to treat gouty arthritis attacks(1,2). ACZ885 is an investigational fully human monoclonal antibody. The studies involved more than 450 gouty...

2011-05-17 12:17:50

Patients with persistent arthritis require more intensive antibiotic and DMARD therapy New research shows that polymerase chain reaction (PCR) testing for Borrelia burgdorferi DNA"”the spirochetal bacteria transmitted by deer ticks"”in joint fluid may confirm the diagnosis of Lyme arthritis, but is not a reliable indicator for active joint infection in patients whose arthritis persists after antibiotic therapy. Findings of this study are published in Arthritis & Rheumatism, a...

2011-04-28 15:05:00

EAST BRUNSWICK, N.J., April 28, 2011 /PRNewswire/ -- Savient Pharmaceuticals, Inc. (Nasdaq: SVNT) today announced that three abstracts will be presented at the European League Against Rheumatism (EULAR) 2011 Annual Congress. The conference will take place on May 25 - 28 in London, United Kingdom, and will feature the abstracts as two oral presentations and one poster presentation. The first scheduled oral presentation and the poster session will address the prevalence of gout in Europe...

2011-04-21 00:00:29

Includes discussion of key development activities in the rheumatology pipeline, perspectives on unmet needs and how different mechanisms are likely to address them, and updates on most promising compounds in development. Scottsdale, AZ (PRWEB) April 20, 2011 MedPredict Market Research, a global provider of pharmaceutical competitive intelligence and market research, has published a new report providing critical strategic insight for companies with a stake in the market for rheumatology...

2011-04-20 00:00:30

We are dedicated to the diagnosis and treatment of people with arthritis and related autoimmune diseases. Appropriate, early treatment helps to preserve function and mobility, relieve or control pain, and improve the ability to perform activities of daily living. Cary, NC (PRWEB) April 18, 2011 Dr Sanjay Chaudhary is an internal medicine and Rheumatology board certified, highly skilled rheumatologist with significant experience acquired as a academic clinical faculty at University of...

2011-04-14 15:15:09

A serendipitous discovery by academics at The University of Nottingham has shown that a simple illusion can significantly reduce "” and in some cases even temporarily eradicate "” arthritic pain in the hand. By tricking the brain into believing that the painful part of the hand is being stretched or shrunk, the researchers were able to halve the pain felt by 85 per cent of sufferers they tested. The research could point to new technologies of the future which could assist patients...

2011-03-16 11:36:00

CHAPEL HILL, N.C., March 16, 2011 /PRNewswire/ -- TSI Healthcare, a national leader in adoption focused healthcare technology solutions, today announced its partnership with The Center for Arthritis and Rheumatic Diseases in San Antonio, Texas. This progressive Rheumatology practice provides both clinical care and research at nine locations. TSI will provide a complete Rheumatology specific solution, including the NextGen(TM) Electronic Health Records (EHR) and Practice Management (EPM)...

2011-03-12 00:00:29

The Spondylitis Association of America's (SAA) online Screening Tool for Ankylosing Spondylitis was featured in a news story on ABCNews.com on March 8. Van Nuys, CA (PRWEB) March 11, 2011 Ankylosing spondylitis (AS) is a crippling form of arthritis that generally strikes young people in their teens and twenties, sometimes even earlier. Left untreated, it causes pain, disability and can eventually cause the spinal vertebrae to fuse together forming one brittle bone, often in a stooped...

2011-03-08 15:44:12

Modified-release therapy is well tolerated in clinical trial Researchers in Europe reported that treatment with modified-release sildenafil significantly reduced the frequency of attacks of Raynaud's phenomenon in patients with limited cutaneous systemic sclerosis (lcSSc), also known as scleroderma. The double-blind, placebo-controlled trial found that sildenafil was well tolerated with only some subjects experiencing minor or moderate side effects. Full findings are available in the March...

2011-03-08 15:35:49

Combination therapy for rheumatoid arthritis has consistent safety profile A recent trial of rituximab in combination with a tumor necrosis factor (TNF) inhibitor and methotrexate (MTX) in patients with active rheumatoid arthritis (RA) found the safety profile to be consistent with other RA trials with TNF inhibitors. While the trial reported no new safety risks, clear evidence of an efficacy advantage in RA patients receiving the combination therapy was not observed in this study sample....


Word of the Day
attercop
  • A spider.
  • Figuratively, a peevish, testy, ill-natured person.
'Attercop' comes from the Old English 'atorcoppe,' where 'atter' means 'poison, venom' and‎ 'cop' means 'spider.' 'Coppa' is a derivative of 'cop,' top, summit, round head, or 'copp,' cup, vessel, which refers to 'the supposed venomous properties of spiders,' says the OED. 'Copp' is still found in the word 'cobweb.'
Related